Valuation : Tasly Pharmaceutical Group Co., Ltd

Market Cap 2.2TCr 327.78Cr 282.06Cr 265.37Cr 242.42Cr 453.49Cr 31TCr 454.73Cr 3.14TCr 1.22TCr 16TCr 1.23TCr 1.2TCr 51TCr P/E 2026 *
16.5x
P/E 2027 * 13.9x
Enterprise Value 2.05TCr 304.78Cr 262.27Cr 246.76Cr 225.41Cr 421.68Cr 29TCr 422.83Cr 2.92TCr 1.13TCr 15TCr 1.14TCr 1.12TCr 48TCr EV / Sales 2026 *
2.37x
EV / Sales 2027 * 1.74x
Free-Float
47.11%
Yield 2026 *
2.64%
Yield 2027 * 3.2%
1 day+0.34%
1 week-1.07%
Current month+0.34%
1 month-6.30%
3 months+3.81%
6 months+6.05%
Current year-2.26%
1 week 14.56
Extreme 14.56
14.92
1 month 14.56
Extreme 14.56
15.97
Current year 12.9
Extreme 12.9
16.24
1 year 12.9
Extreme 12.9
16.53
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 08/05/2024
Director of Finance/CFO 49 09/07/2018
Chief Investment Officer 45 01/05/2025
Director TitleAgeSince
Director/Board Member 72 02/06/2021
Chairman 54 10/08/2026
Director/Board Member 58 08/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%-1.07%-10.18%+5.44% 327.78Cr
+0.49%+2.04%-13.96%-6.39% 1.36TCr
+1.17%-1.39%-31.21%-56.47% 493.14Cr
+2.06%-1.16%-1.26%-3.48% 461.52Cr
+0.95%-1.92%-3.17%-30.82% 394.93Cr
-0.06%-1.29%-21.67%+1.64% 356.76Cr
+0.82%+2.75%+0.08%-0.77% 353.37Cr
0.00%-2.11%-22.33%-16.15% 233.26Cr
-0.20%-2.69%-27.64%-16.84% 168.03Cr
-0.45%-2.44%-2.01%-15.09% 165.99Cr
Average +0.51%+0.07%-13.34%-13.89% 431.07Cr
Weighted average by Cap. +0.66%+0.54%-13.31%-13.29%

Financials

2026 *2027 *
Net sales 863.35Cr 128.6Cr 110.66Cr 104.11Cr 95Cr 177.92Cr 12TCr 178.4Cr 1.23TCr 477.41Cr 6.23TCr 482.9Cr 472.37Cr 20TCr 935.65Cr 139.37Cr 119.93Cr 112.83Cr 103.07Cr 192.82Cr 13TCr 193.34Cr 1.33TCr 517.39Cr 6.75TCr 523.34Cr 511.92Cr 22TCr
Net income 133.72Cr 20Cr 17Cr 16Cr 15Cr 28Cr 1.88TCr 28Cr 190.55Cr 74Cr 964.84Cr 75Cr 73Cr 3.11TCr 158.03Cr 24Cr 20Cr 19Cr 17Cr 33Cr 2.22TCr 33Cr 225.2Cr 87Cr 1.14TCr 88Cr 86Cr 3.67TCr
Net Debt -154.39Cr -23Cr -20Cr -19Cr -17Cr -32Cr -2.17TCr -32Cr -220.01Cr -85Cr -1.11TCr -86Cr -84Cr -3.59TCr -571.22Cr -85Cr -73Cr -69Cr -63Cr -117.72Cr -8.03TCr -118.04Cr -813.99Cr -315.86Cr -4.12TCr -319.5Cr -312.53Cr -13TCr
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
04/26/04 CN¥14.73 +0.34% 1,01,94,160
03/26/03 CN¥14.68 +0.34% 1,00,72,372
02/26/02 CN¥14.63 -0.88% 1,03,24,170
01/26/01 CN¥14.76 +0.54% 1,27,83,525
31/26/31 CN¥14.68 -1.41% 1,62,19,537
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.73CNY
Average target price
17.29CNY
Spread / Average Target
+17.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600535 Stock